Thomas C Lynn is a notable inventor based in San Clemente, CA (US). He has made significant contributions to the field of mass spectrometry, holding a total of 5 patents. His work focuses on the detection and quantification of various biochemical compounds, which has important implications in medical diagnostics.

Latest Patents

Among his latest patents is the invention titled "Mass spectrometric determination of tert-butyldimethylsilyl derivatized methylmalonic acid." This invention relates to the detection of methylmalonic acid (MMA) and outlines methods for detecting derivatized MMA by mass spectrometry. Another significant patent is "Detection and quantitation of guanidinoacetate, creatine, and creatinine by mass spectrometry." This patent provides methods for detecting or determining the amounts of guanidinoacetate (GAA), creatine, and creatinine using mass spectrometry.

Career Highlights

Thomas C Lynn is currently associated with Quest Diagnostics Investments, Inc., where he continues to innovate in the field of mass spectrometry. His work has been instrumental in advancing diagnostic techniques that are crucial for patient care.

Collaborations

Throughout his career, Thomas has collaborated with notable colleagues such as Scott Goldman and Julie A Neidich. These collaborations have further enhanced the impact of his inventions in the scientific community.

Conclusion

Thomas C Lynn is a distinguished inventor whose work in mass spectrometry has led to significant advancements in biochemical detection methods. His contributions are vital for improving diagnostic capabilities in healthcare.

This text is generated by artificial intelligence and may not be accurate.